Leon Bernal-Mizrachi, Ruemu Birhiray, Murtaza Bhuriwala, Robert Rifkin, Roger Lyons, Christopher Yasenchak, Stephen Noga, Isabel Ferreira, Dasha Cherepanov, Alexandra Savell, Yunlong Xie, Saulius Girnius. "Patient-reported outcomes and actigraphy following in-class transition (iCT) from parenteral bortezomib (V) to oral ixazomib in newly diagnosed multiple myeloma (NDMM): Subgroup analysis of US MM-6 by race/ethnicity, renal function, and area income." Blood, 2025. doi:10.1182/blood-2025-4004